was read the article
array:24 [ "pii" => "S1807593222023821" "issn" => "18075932" "doi" => "10.1590/S1807-59322010000700012" "estado" => "S300" "fechaPublicacion" => "2010-01-01" "aid" => "2382" "copyright" => "CLINICS" "copyrightAnyo" => "2010" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "rev" "cita" => "Clinics. 2010;65:723-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S1807593222023833" "issn" => "18075932" "doi" => "10.1590/S1807-59322010000700013" "estado" => "S300" "fechaPublicacion" => "2010-01-01" "aid" => "2383" "copyright" => "CLINICS" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "rev" "cita" => "Clinics. 2010;65:729-38" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Fructose and Cardiometabolic Disorders: The Controversy Will, and Must, Continue" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "729" "paginaFinal" => "738" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig2" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 315 "Ancho" => 512 "Tamanyo" => 28196 ] ] "descripcion" => array:1 [ "en" => "<p id="spara20" class="elsevierStyleSimplePara elsevierViewall">Summary of short- and long-term metabolic and vascular disturbances and the underlying mechanistic pathways induced by high fructose intake.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Nicolas Wiernsperger, Alain Geloen, Jean-Robert Rapin" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Nicolas" "apellidos" => "Wiernsperger" ] 1 => array:2 [ "nombre" => "Alain" "apellidos" => "Geloen" ] 2 => array:2 [ "nombre" => "Jean-Robert" "apellidos" => "Rapin" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222023833?idApp=UINPBA00004N" "url" => "/18075932/0000006500000007/v1_202212010714/S1807593222023833/v1_202212010714/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S180759322202381X" "issn" => "18075932" "doi" => "10.1590/S1807-59322010000700011" "estado" => "S300" "fechaPublicacion" => "2010-01-01" "aid" => "2381" "copyright" => "CLINICS" "documento" => "article" "crossmark" => 0 "licencia" => "https://creativecommons.org/licenses/by-nc/3.0/" "subdocumento" => "fla" "cita" => "Clinics. 2010;65:715-21" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Basic Research</span>" "titulo" => "S-Nitroso-N-Acetylcysteine Ameliorates Ischemia-Reperfusion Injury In The Steatotic Liver" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "715" "paginaFinal" => "721" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 299 "Ancho" => 401 "Tamanyo" => 25478 ] ] "descripcion" => array:1 [ "en" => "<p id="spara10" class="elsevierStyleSimplePara elsevierViewall">Structures in the portal triad (hepatic artery, portal vein, and bile duct) in the median and left lateral hepatic lobes (70% of the liver) clamped with an atraumatic, microvascular clamp.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Wellington Andraus, Gabriela Freitas Pereira de Souza, Marcelo Ganzarolli de Oliveira, Luciana B.P. Haddad, Ana Maria M. Coelho, Flavio Henrique Galvão, Regina Maria Cubero Leitão, Luiz Augusto Carneiro D’Albuquerque, Marcel Cerqueira Cesar Machado" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Wellington" "apellidos" => "Andraus" ] 1 => array:2 [ "nombre" => "Gabriela Freitas Pereira" "apellidos" => "de Souza" ] 2 => array:2 [ "nombre" => "Marcelo Ganzarolli" "apellidos" => "de Oliveira" ] 3 => array:2 [ "nombre" => "Luciana B.P." "apellidos" => "Haddad" ] 4 => array:2 [ "nombre" => "Ana Maria M." "apellidos" => "Coelho" ] 5 => array:2 [ "nombre" => "Flavio Henrique" "apellidos" => "Galvão" ] 6 => array:2 [ "nombre" => "Regina Maria Cubero" "apellidos" => "Leitão" ] 7 => array:2 [ "nombre" => "Luiz Augusto Carneiro" "apellidos" => "D’Albuquerque" ] 8 => array:2 [ "nombre" => "Marcel Cerqueira Cesar" "apellidos" => "Machado" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S180759322202381X?idApp=UINPBA00004N" "url" => "/18075932/0000006500000007/v1_202212010714/S180759322202381X/v1_202212010714/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Anti-Hypertensive Drugs Have Different Effects on Ventricular Hypertrophy Regression" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "723" "paginaFinal" => "728" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Celso Ferreira Filho, Luiz Carlos de Abreu, Vitor E. Valenti, Marcelo Ferreira, Adriano Meneghini, José Alexandre Silveira, Andrés R. Pérez Riera, Eduardo Colombari, Neif Murad, Paulo Roberto Santos-Silva, Lovian José Henrique Pereira da Silva, Luiz Carlos Marques Vanderlei, Tatiana D. Carvalho" "autores" => array:14 [ 0 => array:4 [ "nombre" => "Celso Ferreira" "apellidos" => "Filho" "email" => array:2 [ 0 => "celsoferreira.dmed@epm.br" 1 => "ferreira-celso@uol.com.br" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor1" ] ] ] 1 => array:3 [ "nombre" => "Luiz Carlos" "apellidos" => "de Abreu" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "aff2" ] ] ] 2 => array:3 [ "nombre" => "Vitor E." "apellidos" => "Valenti" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "aff2" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">III</span>" "identificador" => "aff3" ] ] ] 3 => array:3 [ "nombre" => "Marcelo" "apellidos" => "Ferreira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] ] ] 4 => array:3 [ "nombre" => "Adriano" "apellidos" => "Meneghini" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] ] ] 5 => array:3 [ "nombre" => "José Alexandre" "apellidos" => "Silveira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] ] ] 6 => array:3 [ "nombre" => "Andrés R." "apellidos" => "Pérez Riera" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] ] ] 7 => array:3 [ "nombre" => "Eduardo" "apellidos" => "Colombari" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">II</span>" "identificador" => "aff2" ] ] ] 8 => array:3 [ "nombre" => "Neif" "apellidos" => "Murad" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] ] ] 9 => array:3 [ "nombre" => "Paulo Roberto" "apellidos" => "Santos-Silva" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] ] ] 10 => array:3 [ "nombre" => "Lovian José Henrique Pereira da" "apellidos" => "Silva" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] ] ] 11 => array:3 [ "nombre" => "Luiz Carlos Marques" "apellidos" => "Vanderlei" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">IV</span>" "identificador" => "aff4" ] ] ] 12 => array:3 [ "nombre" => "Tatiana D." "apellidos" => "Carvalho" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">III</span>" "identificador" => "aff3" ] ] ] 13 => array:3 [ "nombre" => "Celso" "apellidos" => "Ferreira" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">I</span>" "identificador" => "aff1" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">III</span>" "identificador" => "aff3" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Departamento de Clínica Médica, Disciplina de Cardiologia, Faculdade de Medicina do ABC - Santo André/SP, Brasil" "etiqueta" => "I" "identificador" => "aff1" ] 1 => array:3 [ "entidad" => "Departamento de Morfologia e Fisiologia, Faculdade de Medicina do ABC - Santo André/SP, Brasil" "etiqueta" => "II" "identificador" => "aff2" ] 2 => array:3 [ "entidad" => "Departamento de Medicina, Disciplina de Cardiologia, Universidade Federal de São Paulo (UNIFESP) - São Paulo/SP, Brasil" "etiqueta" => "III" "identificador" => "aff3" ] 3 => array:3 [ "entidad" => "Departamento de Fisioterapia da Faculdade de Ciências e Tecnologia, Universidade Estadual Paulista (FCT – UNESP) - Presidente Prudente/SP, Brasil" "etiqueta" => "IV" "identificador" => "aff4" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "*" "correspondencia" => "Tel.: 55 11 4993-5403" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="cesec10" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle60">INTRODUCTION</span><p id="para10" class="elsevierStylePara elsevierViewall">Cardiac hypertrophy consists of an increase in myocardial mass that results in persistent pressure and/or volume overload.<a class="elsevierStyleCrossRef" href="#bib1">1</a> In myocytes, hyperplasia is limited because of the cells’ differentiated profile, that most closely resembles a short period of time that ends immediately after birth.<a class="elsevierStyleCrossRef" href="#bib1">1</a> The high prevalence of ventricular dysfunction is used to support the view that the ability to regenerate after injury is not significant. However, research has shown that myocyte regeneration is fundamental to heart homeostasis.<a class="elsevierStyleCrossRef" href="#bib2">2</a> For instance, during aortic stenosis, the combination of hypertrophy and hyperplasia increases cardiac mass<a class="elsevierStyleCrossRef" href="#bib3">3</a> at specific locations, such as the site of a therapeutic stem cell implant.<a class="elsevierStyleCrossRef" href="#bib2">2</a></p><p id="para20" class="elsevierStylePara elsevierViewall">Remodeling manifests itself in almost all cardiac diseases and was initially considered beneficial because it compensates for the increased hemodynamic overload and ventricular wall stress and optimizes both function and energy expenditure.<a class="elsevierStyleCrossRef" href="#bib1">1</a> In some circumstances, remodeling is also considered to be an adaptive phenomenon that increases heart performance during work overload. This phenomenon is a result of protein synthesis and either the incorporation of new units into contractile myocytes or the addition of new sarcomeres.<a class="elsevierStyleCrossRef" href="#bib3">3</a> Nevertheless, the benefits of this process are limited by the rate of maintenance, which promotes deleterious changes characterizing this feature as uniquely unfavorable.<a class="elsevierStyleCrossRef" href="#bib4">4</a></p><p id="para30" class="elsevierStylePara elsevierViewall">The mechanisms leading to myocardial injuries<a class="elsevierStyleCrossRefs" href="#bib5">5–9</a> and hypertrophy<a class="elsevierStyleCrossRefs" href="#bib10">10–12</a> during physiological or pathological states are different. For instance, the pathological hypertrophy results from the interaction of mechanical forces and neural and hormonal factors. Hemodynamic overload promotes myocyte stretch, the release of intracellular calcium, the activation of calcineurin and the induction of gene expression reprogramming.<a class="elsevierStyleCrossRef" href="#bib1">1</a> In athletes, left ventricular hypertrophy (LVH) is regarded as a physiological response that results from a hemodynamic overload; this physiological response does not result in the harmful effects of hypertension development or other heart diseases.<a class="elsevierStyleCrossRefs" href="#bib10">10–12</a> The literature explains physiological LVH as the result of a volume and pressure overload that results from intense physical training (the hemodynamic stimulus), which is not necessarily accompanied by neural and humoral changes.<a class="elsevierStyleCrossRef" href="#bib13">13</a></p><p id="para40" class="elsevierStylePara elsevierViewall">Despite some initial benefits of physiological hypertrophy, it is difficult to determine the time at which physiological hypertrophy becomes pathological<a class="elsevierStyleCrossRef" href="#bib1">1</a> and represents a significant morbidity and mortality risk. In other words, it is difficult to pinpoint exactly when, during the natural development of hypertension, cardiac hypertrophy raises an individual’s risk of experiencing a cardiovascular event by a reported factor of six to eight times.<a class="elsevierStyleCrossRef" href="#bib3">3</a></p><p id="para50" class="elsevierStylePara elsevierViewall">There are well-known associations between LVH and several conditions, such as obesity, diabetes, myocardial infarction and even mild elevation in blood pressure,<a class="elsevierStyleCrossRef" href="#bib1">1</a> as well as other cardiovascular risk factors that may be associated with increased cardiac mass regardless of ventricular pressure. Therefore, LVH is a powerful predictor of cardiovascular morbidity and mortality.<a class="elsevierStyleCrossRef" href="#bib3">3</a> Clinical and experimental studies have reported that several pharmacological, hemodynamic and non-hemodynamic factors are able to induce, reverse and prevent LVH,<a class="elsevierStyleCrossRefs" href="#bib14">14–16</a> interstitial fibrosis<a class="elsevierStyleCrossRef" href="#bib17">17</a> and the progression of atherosclerotic effects on myocytes.<a class="elsevierStyleCrossRef" href="#bib18">18</a> Clinically, cardiac hypertrophy is associated with increased adverse events, including stroke, chronic renal failure, ventricular dysfunction, ventricular arrhythmias and sudden death.<a class="elsevierStyleCrossRef" href="#bib3">3</a> Cardiac hypertrophy is also associated with a higher prevalence of coronary disease and is related to endothelial dysfunction. This dysfunction may lead to myocardial ischemia, even in the absence of epicardial artery obstruction, by reducing coronary flow reserves due to various hemodynamic factors, such as a minimal reduction in coronary resistance, systolic coronary perivascular compression, collagen deposition, fibrosis and a lower production of local vasodilator substances, such as nitric oxide.<a class="elsevierStyleCrossRef" href="#bib19">19</a></p><p id="para60" class="elsevierStylePara elsevierViewall">After adjusting for other risk factors, Koren and coworkers<a class="elsevierStyleCrossRef" href="#bib20">20</a> reported a positive relationship between ventricular mass and geometry with the morbidity and mortality of patients who did not have complicated hypertension.<a class="elsevierStyleCrossRef" href="#bib20">20</a> The Framingham Heart Study, published by Levy et al<a class="elsevierStyleCrossRef" href="#bib21">21</a> included 3,220 healthy subjects aged 40 years or older. This study demonstrated that estimating left ventricular mass by echocardiography can provide prognostic information about cardiovascular risk and can predict negative cardiovascular-related clinical events, including death.<a class="elsevierStyleCrossRef" href="#bib21">21</a> Moreover, LVH increased the risk of major cardiovascular events in 40% of the patients enrolled in the study.<a class="elsevierStyleCrossRef" href="#bib21">21</a></p><p id="para70" class="elsevierStylePara elsevierViewall">From these previous investigations, we infer that LVH constitutes an ominous risk factor for cardiovascular disease and that the magnitude of this risk is directly related to morbidity and mortality rates. Therefore, in this study, we endeavored to describe the effects of anti-hypertensive drugs on cardiac hypertrophy by a meta-analysis of previous studies.</p></span><span id="cesec20" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle70">METHODS</span><p id="para80" class="elsevierStylePara elsevierViewall">The Medline (via PubMed), Lilacs and Scielo databases were searched using the following subject keywords: “cardiac hypertrophy,” “antihypertensive” and “mortality.” We also used the “related articles” function on PubMed, Lilacs and Scielo, which allowed us to search the references of the studies that were retrieved during our search. Publications were included in our review if either their titles or abstracts were available in English or Portuguese and suggested any effect (i.e., beneficial or malefic) or lack thereof from an anti-hypertensive treatment on cardiac hypertrophy. The review was completed in March, 2010. Publications were excluded if the treatment was limited to a particular technique or if the population received only one specific procedure (drug treatment) associated with a disease state or an age group. Other studies on anti-hypertensive treatment for hypertensive patients that offered additional relevant information found in the same database were also examined. Each publication was reviewed to identify the author(s), study period and data source, which influenced us to include the reference in the study.</p></span><span id="cesec30" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle80">RESULTS</span><p id="para90" class="elsevierStylePara elsevierViewall">A total of 694 manuscripts met the inclusion criteria for our study. We excluded investigations in which treatment was limited to a particular method and those studies in which the study population was limited to patients who were undergoing a particular procedure or an associated disease state.</p><p id="para100" class="elsevierStylePara elsevierViewall">In <a class="elsevierStyleCrossRef" href="#t1-cln_65p723">Table 1</a>, we summarize studies that evaluated the relationship between anti-hypertensive drugs and cardiac hypertrophy. The investigations included in <a class="elsevierStyleCrossRef" href="#t1-cln_65p723">Table 1</a> demonstrate the relevance of angiotensin-converting enzyme (ACE) inhibitors<a class="elsevierStyleCrossRefs" href="#bib14">14,15,22–24</a> and angiotensin antagonist<a class="elsevierStyleCrossRef" href="#bib25">25</a> treatment for cardiac hypertrophy regression.</p><elsevierMultimedia ident="t1-cln_65p723"></elsevierMultimedia></span><span id="cesec40" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle90">DISCUSSION</span><span id="cesec50" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle100">Regression of left ventricular hypertrophy</span><p id="para110" class="elsevierStylePara elsevierViewall">The high prevalence of LVH and the high rate of complications of its condition necessitate a thorough understanding of the mechanisms involved in its etiology and development, as well as the importance of prevention and regression, to optimize and prevent the deleterious consequences. Thus, it is important to clarify the following issues, which are described below.</p></span><span id="cesec60" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle110">Relationship between LVH regression and cardiovascular morbidity and mortality</span><p id="para120" class="elsevierStylePara elsevierViewall">Several published reports have provided data indicating that anti-hypertensive drugs promote ventricular hypertrophy regression and myocardial repair. In particular, ACE inhibitors have shown promising cardio-protective effects in experimental models of hypertensive heart disease;<a class="elsevierStyleCrossRef" href="#bib22">22</a> specifically, these inhibitors improve micro-vascular ischemia, ventricular function and arrhythmias.<a class="elsevierStyleCrossRefs" href="#bib14">14–16</a>, <a class="elsevierStyleCrossRefs" href="#bib23">23–29</a> We have previously reported that enalapril<a class="elsevierStyleCrossRef" href="#bib14">14</a> (ACE inhibitor) and verapamil<a class="elsevierStyleCrossRef" href="#bib23">23</a> (Ca<span class="elsevierStyleSup">++</span> channel blocker) provide the same cardio-protector response in an isoproterenol-induced LVH model in rats.<a class="elsevierStyleCrossRef" href="#bib28">28</a></p><p id="para130" class="elsevierStylePara elsevierViewall">To evaluate the effects of LVH and its regression, a previous study evaluated 151 patients with hypertension and LVH progression detected by echocardiography. The patients were followed for an average of 10 years+1.4 years, and the researchers noted a decrease in the non-fatal events rate following reduction of LVH, even after correcting for other risk factors. Conversely, the occurrence of these events increased when cardiac hypertrophy increased or remained stable.<a class="elsevierStyleCrossRef" href="#bib23">23</a></p><p id="para140" class="elsevierStylePara elsevierViewall">Another clinical investigation examined 430 patients with essential hypertension (also called primary or idiopathic hypertension) and related changes in the left ventricular mass with the occurrence of cardiovascular events. Treatments consisted of medication and lifestyle changes. At the 2 years and 9 months follow-up assessment, the prevalence of LVH by echocardiography was 26% per year, and the rate of cardiovascular events was 3.9% per year. For individuals who showed an improvement in LVH, the rate of cardiovascular events was 1.58 events per 100 patients per year. In the groups that experienced no change or a worsening in LVH, the rate of cardiovascular events was 6.27 events per 100 patients per year. These researchers also noted that this association did not depend on the initial ventricular mass, clinical parameters or monitored baseline blood pressure. Their final conclusion was that for primary hypertension, the decrease in ventricular mass during treatment is a favorable prognostic marker for subsequent morbid events.</p></span><span id="cesec70" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle120">Relationship between anti-hypertensive drugs and LVH regression</span><p id="para150" class="elsevierStylePara elsevierViewall">With the exception of minoxidil and hydralazine, which are peripheral vasodilators, the other anti-hypertensive drugs provided full or partial LVH regression.<a class="elsevierStyleCrossRef" href="#bib28">28</a> Not all classification, prospective and randomized studies that have evaluated the effectiveness of various drugs with respect to left ventricular mass reduction have reported evidence of a difference between their effects on LVH regression.<a class="elsevierStyleCrossRef" href="#bib23">23</a> However, in view of the different effects of the drugs, those drugs that depend on neural and humoral mechanisms, especially as reported in monotherapy studies, provide evidence that there may be several ways in which the drugs’ properties could reduce ventricular mass. In the literature, there are few monotherapy treatment meta-analyses. In addition, different groups report contradictory results.<a class="elsevierStyleCrossRef" href="#bib23">23</a> Most studies have used anti-hypertensive drugs (i.e., beta-blockers and diuretics) and reported 5–8% reductions of the left ventricular mass, while the use of ACE inhibitors and angiotensin AT1 blockers resulted in a 13% reduction. The difference between different anti-hypertensive drugs regarding their ability to reverse LVH may be determined by neural and humoral factors.<a class="elsevierStyleCrossRef" href="#bib30">30</a></p><p id="para160" class="elsevierStylePara elsevierViewall">Because LVH regression is an important intermediate objective of anti-hypertensive therapy, several trials and meta-analyses have compared the effects of these drugs on ventricular hypertrophy, but the usefulness of these studies is limited due to inadequate designs and methodological problems.<a class="elsevierStyleCrossRef" href="#bib32">32</a> The PRESERVE (Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement),<a class="elsevierStyleCrossRef" href="#bib33">33</a> LIVE (Indapamide Sustained Release Versus Enalapril)<a class="elsevierStyleCrossRef" href="#bib34">34</a> and LIFE (Losartan Intervention for Endpoint in Hypertension)<a class="elsevierStyleCrossRef" href="#bib25">25</a> studies represent a new generation of well-planned trials comparing different anti-hypertensive drugs. These investigations revealed that during regression of LVH, the effects of nifedipine and enalaprilat are similar (PRESERVE); indapamine has a stronger effect than does enalapril (LIVE); and losartan treatment has a stronger effect than atenolol (LIFE).</p><p id="para170" class="elsevierStylePara elsevierViewall">The findings of these three studies conflict with the findings of some previous meta-analyses, and as such, these researchers have suggested that the effects of anti-hypertensive drug must be evaluated individually on their important intermediate targets, such as LVH, with appropriate patient populations. The extrapolation of the LVH regression effects based on the anti-hypertensive drug classification may lead to clinical mistakes and needs to be carefully reconsidered.<a class="elsevierStyleCrossRef" href="#bib23">23</a></p></span><span id="cesec80" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle130">Mechanisms besides the decreased hemodynamic overload that may be responsible for LVH regression</span><p id="para180" class="elsevierStylePara elsevierViewall">A decrease in blood pressure may reduce a ventricular mass. In addition to clinical studies, experimental studies have demonstrated that LVH prevention and/or regression is independent of blood pressure. For instance, our group investigated isoproterenol-induced LVH in albino rats, which typically leads to hypertrophy without an increase in the after-load, and reported LVH regression by gavage administration of enalapril<a class="elsevierStyleCrossRef" href="#bib15">15</a>, <a class="elsevierStyleCrossRef" href="#bib16">16</a>, <a class="elsevierStyleCrossRef" href="#bib28">28</a>, <a class="elsevierStyleCrossRef" href="#bib31">31</a> and verapamil.<a class="elsevierStyleCrossRef" href="#bib23">23</a>, <a class="elsevierStyleCrossRef" href="#bib30">30</a></p><p id="para190" class="elsevierStylePara elsevierViewall">Moreover, studies in spontaneously hypertensive rats, a rat strain commonly used in our laboratory<a class="elsevierStyleCrossRefs" href="#bib35">35–39</a>, demonstrated that although various anti-hypertensive drugs may control systemic hypertension, LVH may be influenced by many, but not all, anti-hypertensive agents. Alpha-methyldopa, captopril, beta-blockers and calcium channel blockers promote the regression of hypertrophy, while other drugs, such as hydralazine and minoxidil, reduce blood pressure without influencing ventricular hypertrophy.<a class="elsevierStyleCrossRef" href="#bib23">23</a></p><p id="para200" class="elsevierStylePara elsevierViewall">However, the development of LVH in arterial hypertension may be explained primarily by an increased pressure overload and ventricular wall tension. The ratio of ventricular mass to pressure is often weak, even in relation to blood pressure monitored every 24 hours.<a class="elsevierStyleCrossRef" href="#bib3">3</a> Notably, LVH may occur independently from changes in arterial pressure and be present even when hypertension does not develop.<a class="elsevierStyleCrossRef" href="#bib1">1</a> We may include the presence of others factors involved in this condition, such as lifestyle, anthropometric and demographic characteristics, genetic influences and neural and humoral factors.<a class="elsevierStyleCrossRef" href="#bib24">24</a></p><p id="para210" class="elsevierStylePara elsevierViewall">Furthermore, <span class="elsevierStyleItalic">in vivo</span>, <span class="elsevierStyleItalic">in vitro</span> and genetic studies indicate that LVH development and its regression depends not only on the hemodynamic overload but also on other genetic, neural and humoral factors.<a class="elsevierStyleCrossRef" href="#bib9">9</a> Humoral agents that may affect mitogenesis and non-myocyte cardiomyocytes have been identified; these agents include the renin-angiotensin system, local norepinephrine, endothelin, transforming growth factor, insulin-like growth factor, bradykinin, prostaglandins and nitric oxide.<a class="elsevierStyleCrossRef" href="#bib23">23</a> The direct relationship between high blood pressure and LVH development has been questioned due to the fact that LVH development and its regression depends not only on the hemodynamic overload, forcing a review of the mechanisms involved in LVH development, such as the role of the sympathetic nervous system, the renin-angiotensin system, genetic factors, endothelin and endothelium.<a class="elsevierStyleCrossRef" href="#bib1">1</a> It is important to remember that the pathogenesis of LVH includes angiotensin II receptors and membrane-stretched cardiomyocytes.<a class="elsevierStyleCrossRef" href="#bib2">2</a></p><p id="para220" class="elsevierStylePara elsevierViewall">Several publications have reported that although anti-hypertensive drugs show non-uniform effects on LVH, there are no concomitant proportional decreases in blood pressure.<a class="elsevierStyleCrossRef" href="#bib13">13</a>, <a class="elsevierStyleCrossRef" href="#bib20">20</a> Conversely, anti-hypertensive drugs have promoted different effects on LVH, despite inducing similar reductions in blood pressure.<a class="elsevierStyleCrossRef" href="#bib4">4</a> Those assumptions lead us to consider other mechanisms involved in LVH regression that are independent of blood pressure reduction.</p></span><span id="cesec90" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle140">Intrinsic properties of anti-hypertensives on LVH regression: beyond blood pressure?</span><p id="para230" class="elsevierStylePara elsevierViewall">A decrease in cardiac mass may not depend only on daily arterial pressure measurement.<a class="elsevierStyleCrossRef" href="#bib23">23</a> Recently, Mayos et al.<a class="elsevierStyleCrossRef" href="#bib40">40</a> localized chromosome regions that harbor genetic variants that affect the diversity of electrocardiographic and echocardiographic LVH. They evaluated the genetic association of the Sokolow-Lyon voltage index and the Cornell product index, the septal thickness and the ventricular wall, ventricular dimensions and left ventricular mass in 868 members of 224 British households, all items were evaluated n pairs and together. Chromosomes 10, 12 and 17 were the genetic <span class="elsevierStyleItalic">loci</span> involved and had the most important influence on LVH, as detected by the electrocardiogram.<a class="elsevierStyleCrossRef" href="#bib23">23</a></p><p id="para240" class="elsevierStylePara elsevierViewall">Genetic factors may explain a substantial portion of the quantitative variability in the electrocardiographic and echocardiographic examinations due to hemodynamic and/or hormonal factors. However, the quantitative differences in LVH, known as phenotypes, may also be the result of individual differences besides those produced by the various anti-hypertensive drugs (i.e., beyond blood pressure).</p></span></span><span id="cesec100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle150">CONCLUSION</span><p id="para250" class="elsevierStylePara elsevierViewall">LVH is an important marker of poor prognosis. Current medical literature shows the direct relationship between LVH and mortality, as well as the relationship between LVH regression and decreasing mortality. The literature also provides evidence for hypertrophic variations in response to the effect of different anti-hypertensive drugs and differences in the hemodynamic patterns.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:8 [ 0 => array:2 [ "identificador" => "xpalclavsec1581266" "titulo" => "KEYWORDS" ] 1 => array:2 [ "identificador" => "cesec10" "titulo" => "INTRODUCTION" ] 2 => array:2 [ "identificador" => "cesec20" "titulo" => "METHODS" ] 3 => array:2 [ "identificador" => "cesec30" "titulo" => "RESULTS" ] 4 => array:3 [ "identificador" => "cesec40" "titulo" => "DISCUSSION" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "cesec50" "titulo" => "Regression of left ventricular hypertrophy" ] 1 => array:2 [ "identificador" => "cesec60" "titulo" => "Relationship between LVH regression and cardiovascular morbidity and mortality" ] 2 => array:2 [ "identificador" => "cesec70" "titulo" => "Relationship between anti-hypertensive drugs and LVH regression" ] 3 => array:2 [ "identificador" => "cesec80" "titulo" => "Mechanisms besides the decreased hemodynamic overload that may be responsible for LVH regression" ] 4 => array:2 [ "identificador" => "cesec90" "titulo" => "Intrinsic properties of anti-hypertensives on LVH regression: beyond blood pressure?" ] ] ] 5 => array:2 [ "identificador" => "cesec100" "titulo" => "CONCLUSION" ] 6 => array:2 [ "identificador" => "xack638809" "titulo" => "Acknowledgments" ] 7 => array:1 [ "titulo" => "REFERENCES" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2010-04-01" "fechaAceptado" => "2010-04-06" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "KEYWORDS" "identificador" => "xpalclavsec1581266" "palabras" => array:5 [ 0 => "Hypertrophy" 1 => "Cardiomyopathy" 2 => "Hypertrophic" 3 => "Left ventricle hypertension" 4 => "Cardiology" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="ceabs10" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle10">OBJECTIVES:</span><p id="spara20" class="elsevierStyleSimplePara elsevierViewall">There is a direct relationship between the regression of left ventricular hypertrophy (LVH) and a decreased risk of mortality. This investigation aimed to describe the effects of anti-hypertensive drugs on cardiac hypertrophy through a meta-analysis of the literature.</p></span> <span id="ceabs20" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle20">METHODS:</span><p id="spara30" class="elsevierStyleSimplePara elsevierViewall">The Medline (via PubMed), Lilacs and Scielo databases were searched using the subject keywords cardiac hypertrophy, antihypertensive and mortality. We aimed to analyze the effect of anti-hypertensive drugs on ventricle hypertrophy.</p></span> <span id="ceabs30" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle30">RESULTS:</span><p id="spara40" class="elsevierStyleSimplePara elsevierViewall">The main drugs we described were enalapril, verapamil, nifedipine, indapamina, losartan, angiotensin-converting enzyme inhibitors and atenolol. These drugs are usually used in follow up programs, however, the studies we investigated used different protocols. Enalapril (angiotensin-converting enzyme inhibitor) and verapamil (Ca<span class="elsevierStyleSup">++</span> channel blocker) caused hypertrophy to regress in LVH rats. The effects of enalapril and nifedipine (Ca<span class="elsevierStyleSup">++</span> channel blocker) were similar. Indapamina (diuretic) had a stronger effect than enalapril, and losartan (angiotensin II receptor type 1 (AT1) receptor antagonist) produced better results than atenolol (selective β1 receptor antagonist) with respect to LVH regression.</p></span> <span id="ceabs40" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cestitle40">CONCLUSION:</span><p id="spara50" class="elsevierStyleSimplePara elsevierViewall">The anti-hypertensive drugs induced various degrees of hypertrophic regression.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "ceabs10" "titulo" => "OBJECTIVES:" ] 1 => array:2 [ "identificador" => "ceabs20" "titulo" => "METHODS:" ] 2 => array:2 [ "identificador" => "ceabs30" "titulo" => "RESULTS:" ] 3 => array:2 [ "identificador" => "ceabs40" "titulo" => "CONCLUSION:" ] ] ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "t1-cln_65p723" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="top" scope="col"><span class="elsevierStyleItalic">Author and year</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="top" scope="col"><span class="elsevierStyleItalic">Main finding(s)</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Costa et al., 1997<a class="elsevierStyleCrossRef" href="#bib14">14</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Enalaprilat inhibited isoproterenol-induced LVH action on cardiomyocytes, partially prevented the LVH and decreased the content of collagen fibers in rats. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Tan et al., 1992<a class="elsevierStyleCrossRef" href="#bib22">22</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Angiotensin-converting enzyme inhibition demonstrated promising myocardial remodeling effects in experimental models of hypertensive heart disease. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Bombig et al., 1996<a class="elsevierStyleCrossRef" href="#bib23">23</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Verapamil prevented the deleterious effects of isoproterenol in the myocardium of rats. This action was probably due to the prevention of myocardial hypertrophy and collagen tissue proliferation. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Sayegh F et al., 2005<a class="elsevierStyleCrossRef" href="#bib24">24</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Moexipril 15 mg once daily, administered for 24 weeks, resulted in a significant reversal of LVH in patients with essential hypertension. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Dahlöf et al., 2002<a class="elsevierStyleCrossRef" href="#bib25">25</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top">Losartan prevented more cardiovascular morbidity and deaths than did atenolol while inducing a similar reduction in blood pressure and is better tolerated in humans. Losartan seemed to confer benefits beyond a reduction in blood pressure. \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top" style="border-bottom: 2px solid black">Ferreira Filho et al., 2007<a class="elsevierStyleCrossRef" href="#bib15">15</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="top" style="border-bottom: 2px solid black">Enalaprilat increased the regression of hypertrophy in the left ventricle but not in the diaphragm or the gastrocnemius muscles. \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spara10" class="elsevierStyleSimplePara elsevierViewall">A summary of the main clinical and experimental studies for anti-hypertensive drugs and left ventricular hypertrophy (LVH).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "REFERENCES" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec10" "bibliografiaReferencia" => array:40 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of oxidative stress and lipid peroxidation in ventricular remodeling induced by tobacco smoke exposure after myocardial infarction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ DR Duarte \n \t\t\t\t\t\t\t\t """ 1 => """ MF Minicucci \n \t\t\t\t\t\t\t\t """ 2 => """ PS Azevedo \n \t\t\t\t\t\t\t\t """ 3 => """ BB Matsubara \n \t\t\t\t\t\t\t\t """ 4 => """ LS Matsubara \n \t\t\t\t\t\t\t\t """ 5 => """ EL Novelli \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clinics" "fecha" => "2009" "volumen" => "64" "paginaInicial" => "691" "paginaFinal" => "697" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of pseudo-hypertrophic cardiomyopathy: a congenital heart disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => """ R Ieva \n \t\t\t\t\t\t\t\t """ 1 => """ M Correale \n \t\t\t\t\t\t\t\t """ 2 => """ M Di Biase \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s1807-59322008000400026" "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2008" "volumen" => "63" "paginaInicial" => "557" "paginaFinal" => "560" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18719773" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ K Urbanek \n \t\t\t\t\t\t\t\t """ 1 => """ F Quaini \n \t\t\t\t\t\t\t\t """ 2 => """ G Tasca \n \t\t\t\t\t\t\t\t """ 3 => """ D Torella \n \t\t\t\t\t\t\t\t """ 4 => """ C Castaldo \n \t\t\t\t\t\t\t\t """ 5 => """ B Nadal-Ginard \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Proc Natl Acad Sci U S A" "fecha" => "2003" "volumen" => "100" "paginaInicial" => "10440" "paginaFinal" => "10445" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemodynamic, morphometric and autonomic patterns in hypertensive rats - Renin-Angiotensin system modulation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ FS Zamo \n \t\t\t\t\t\t\t\t """ 1 => """ S Lacchini \n \t\t\t\t\t\t\t\t """ 2 => """ C Mostarda \n \t\t\t\t\t\t\t\t """ 3 => """ S Chiavegatto \n \t\t\t\t\t\t\t\t """ 4 => """ IC Silva \n \t\t\t\t\t\t\t\t """ 5 => """ EM Oliveira \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/S1807-59322010000100013" "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2010" "volumen" => "65" "paginaInicial" => "85" "paginaFinal" => "92" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20126350" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cold stress effects on cardiomyocytes nuclear size in rats: light microscopic evaluation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ A Meneghini \n \t\t\t\t\t\t\t\t """ 1 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 2 => """ LC Abreu \n \t\t\t\t\t\t\t\t """ 3 => """ M Ferreira \n \t\t\t\t\t\t\t\t """ 4 => """ C Ferreira Filho \n \t\t\t\t\t\t\t\t """ 5 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s0102-76382008000400013" "Revista" => array:6 [ "tituloSerie" => "Rev Bras Cir Cardiovasc" "fecha" => "2008" "volumen" => "23" "paginaInicial" => "530" "paginaFinal" => "533" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19229426" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Memantine prevents cardiomyocytes nuclear size reduction in the left ventricle of rats exposed to cold stress" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ A Meneghini \n \t\t\t\t\t\t\t\t """ 1 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 2 => """ LC de Abreu \n \t\t\t\t\t\t\t\t """ 3 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 4 => """ M Ferreira \n \t\t\t\t\t\t\t\t """ 5 => """ CF Filho \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/S1807-59322009000900014" "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2009" "volumen" => "64" "paginaInicial" => "921" "paginaFinal" => "926" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19759887" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fluoxetine effects on mitochondrial ultrastructure of right ventricle in rats exposed to cold stress" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ FV Daud \n \t\t\t\t\t\t\t\t """ 1 => """ N Murad \n \t\t\t\t\t\t\t\t """ 2 => """ A Meneghini \n \t\t\t\t\t\t\t\t """ 3 => """ M Ferreira \n \t\t\t\t\t\t\t\t """ 4 => """ C Ferreira Filho \n \t\t\t\t\t\t\t\t """ 5 => """ LC Abreu \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s0102-76382009000200013" "Revista" => array:6 [ "tituloSerie" => "Rev Bras Cir Cardiovasc" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "173" "paginaFinal" => "179" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19768296" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocardium tissue changes caused by electrical transthoracic discharges in rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ M Ferreira \n \t\t\t\t\t\t\t\t """ 1 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 2 => """ LC de Abreu \n \t\t\t\t\t\t\t\t """ 3 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 4 => """ N Murad \n \t\t\t\t\t\t\t\t """ 5 => """ A Meneghini \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1755-7682-2-31" "Revista" => array:5 [ "tituloSerie" => "Int Arch Med" "fecha" => "2009" "volumen" => "2" "paginaInicial" => "31" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19852820" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ A Meneghini \n \t\t\t\t\t\t\t\t """ 1 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 2 => """ LC Abreu \n \t\t\t\t\t\t\t\t """ 3 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 4 => """ M Ferreira \n \t\t\t\t\t\t\t\t """ 5 => """ N Murad \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Electric countershock and cold stress effects on liver and adrenal gland" "fecha" => "2010" "volumen" => "65" "paginaInicial" => "291" "paginaFinal" => "296" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Endothelial and non-endothelial coronary blood flow reserve and left ventricular dysfunction in systemic hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ AM Rocha \n \t\t\t\t\t\t\t\t """ 1 => """ VM Salemi \n \t\t\t\t\t\t\t\t """ 2 => """ PA Lemos Neto \n \t\t\t\t\t\t\t\t """ 3 => """ AY Matsumoto \n \t\t\t\t\t\t\t\t """ 4 => """ VF Pereira \n \t\t\t\t\t\t\t\t """ 5 => """ F Fernandes \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clinics" "fecha" => "2009" "volumen" => "64" "paginaInicial" => "327" "paginaFinal" => "335" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Profile of cardiovascular risk factors and mortality in patients with symptomatic peripheral arterial disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ SG Zanati \n \t\t\t\t\t\t\t\t """ 1 => """ GG Mouraria \n \t\t\t\t\t\t\t\t """ 2 => """ LS Matsubara \n \t\t\t\t\t\t\t\t """ 3 => """ M Giannini \n \t\t\t\t\t\t\t\t """ 4 => """ BB Matsubara \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s1807-59322009000400010" "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2009" "volumen" => "64" "paginaInicial" => "323" "paginaFinal" => "326" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19488590" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diastolic function predicts outcome after aortic valve replacement in patients with chronic severe aortic regurgitation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ M Cayli \n \t\t\t\t\t\t\t\t """ 1 => """ M Kanada i \n \t\t\t\t\t\t\t\t """ 2 => """ O Akpinar \n \t\t\t\t\t\t\t\t """ 3 => """ A Usal \n \t\t\t\t\t\t\t\t """ 4 => """ H Poyrazo lu \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/clc.20437" "Revista" => array:6 [ "tituloSerie" => "Clin Cardiol" "fecha" => "2009" "volumen" => "32" "paginaInicial" => "E19" "paginaFinal" => "E23" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19455677" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The vital role of papillary muscles in mitral and ventricular function: echocardiographic insights" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => """ EC Madu \n \t\t\t\t\t\t\t\t """ 1 => """ IA D’Cruz \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Cardiol" "fecha" => "1997" "volumen" => "20" "paginaInicial" => "93" "paginaFinal" => "98" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enalaprilat in the prevention of left ventricular hypertrophy induced by isoproterenol" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ EA Costa \n \t\t\t\t\t\t\t\t """ 1 => """ B Luna Filho \n \t\t\t\t\t\t\t\t """ 2 => """ R Póvoa \n \t\t\t\t\t\t\t\t """ 3 => """ C Ferreira Filho \n \t\t\t\t\t\t\t\t """ 4 => """ N Murad \n \t\t\t\t\t\t\t\t """ 5 => """ M Ferreira \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s0066-782x1997000700006" "Revista" => array:6 [ "tituloSerie" => "Arq Bras Cardiol" "fecha" => "1997" "volumen" => "69" "paginaInicial" => "35" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9532814" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Study of the Effects of Enalaprilate Induced by Isoproterenol due Myocardium, Diaphragm and Gastrocnemius" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ C Ferreira Filho \n \t\t\t\t\t\t\t\t """ 1 => """ B Luna Filho \n \t\t\t\t\t\t\t\t """ 2 => """ AP Riera \n \t\t\t\t\t\t\t\t """ 3 => """ A Meneghini \n \t\t\t\t\t\t\t\t """ 4 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Einstein" "fecha" => "2007" "volumen" => "5" "paginaInicial" => "321" "paginaFinal" => "325" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of the prolonged inhibition of the angiotensin-converting enzyme on the morphological and functional characteristics of left ventricular hypertrophy in rats with persistent pressure overload" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ EA Bregagnollo \n \t\t\t\t\t\t\t\t """ 1 => """ K Okoshi \n \t\t\t\t\t\t\t\t """ 2 => """ IF Bregagnollo \n \t\t\t\t\t\t\t\t """ 3 => """ CR Padovani \n \t\t\t\t\t\t\t\t """ 4 => """ MP Okoshi \n \t\t\t\t\t\t\t\t """ 5 => """ AC Cicogna \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s0066-782x2005000300006" "Revista" => array:6 [ "tituloSerie" => "Arq Bras Cardiol" "fecha" => "2005" "volumen" => "84" "paginaInicial" => "225" "paginaFinal" => "232" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15867996" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Left ventricular hypertrophy: a new approach for fibrosis inhibition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => """ ML Muiesan \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00004872-200204000-00015" "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "2002" "volumen" => "20" "paginaInicial" => "611" "paginaFinal" => "613" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11910293" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ P Verdecchia \n \t\t\t\t\t\t\t\t """ 1 => """ F Angeli \n \t\t\t\t\t\t\t\t """ 2 => """ P Achilli \n \t\t\t\t\t\t\t\t """ 3 => """ C Castellani \n \t\t\t\t\t\t\t\t """ 4 => """ A Broccatelli \n \t\t\t\t\t\t\t\t """ 5 => """ R Gattobigio \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/HCO.0b013e3280ebb413" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Cardiol" "fecha" => "2007" "volumen" => "22" "paginaInicial" => "329" "paginaFinal" => "334" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17556886" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrosis and ischemia: the real risks in hypertensive heart disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => """ ED Frohlich \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0895-7061(01)02088-x" "Revista" => array:6 [ "tituloSerie" => "Am J Hypertens" "fecha" => "2001" "volumen" => "14" "paginaInicial" => "194S" "paginaFinal" => "199S" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11411756" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ MJ Koren \n \t\t\t\t\t\t\t\t """ 1 => """ RB Devereux \n \t\t\t\t\t\t\t\t """ 2 => """ PN Casale \n \t\t\t\t\t\t\t\t """ 3 => """ DD Savage \n \t\t\t\t\t\t\t\t """ 4 => """ JH Laragh \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7326/0003-4819-114-5-345" "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1991" "volumen" => "114" "paginaInicial" => "345" "paginaFinal" => "352" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1825164" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ D Levy \n \t\t\t\t\t\t\t\t """ 1 => """ RJ Garrison \n \t\t\t\t\t\t\t\t """ 2 => """ DD Savage \n \t\t\t\t\t\t\t\t """ 3 => """ WB Kannel \n \t\t\t\t\t\t\t\t """ 4 => """ WP Castelli \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199005313222203" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1990" "volumen" => "322" "paginaInicial" => "1561" "paginaFinal" => "1566" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2139921" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => """ LB Tan \n \t\t\t\t\t\t\t\t """ 1 => """ C Brilla \n \t\t\t\t\t\t\t\t """ 2 => """ KT Weber \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Hypertens Suppl" "fecha" => "1992" "volumen" => "10" "paginaInicial" => "S31" "paginaFinal" => "S34" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1359040" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of verapamil on left ventricular hypertrophy induced by isoproterenol" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ MT Bombig \n \t\t\t\t\t\t\t\t """ 1 => """ B Luna Filho \n \t\t\t\t\t\t\t\t """ 2 => """ EA Costa \n \t\t\t\t\t\t\t\t """ 3 => """ DA Leite \n \t\t\t\t\t\t\t\t """ 4 => """ R Póvoa \n \t\t\t\t\t\t\t\t """ 5 => """ N Murad \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arq Bras Cardiol" "fecha" => "1996" "volumen" => "67" "paginaInicial" => "81" "paginaFinal" => "85" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9110438" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ F Sayegh \n \t\t\t\t\t\t\t\t """ 1 => """ J Topouchian \n \t\t\t\t\t\t\t\t """ 2 => """ M Hlawaty \n \t\t\t\t\t\t\t\t """ 3 => """ M Olzewska \n \t\t\t\t\t\t\t\t """ 4 => """ R Asmar \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00045391-200501000-00002" "Revista" => array:6 [ "tituloSerie" => "Am J Ther" "fecha" => "2005" "volumen" => "12" "paginaInicial" => "3" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15662286" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ B Dahlöf \n \t\t\t\t\t\t\t\t """ 1 => """ RB Devereux \n \t\t\t\t\t\t\t\t """ 2 => """ SE Kjeldsen \n \t\t\t\t\t\t\t\t """ 3 => """ S Julius \n \t\t\t\t\t\t\t\t """ 4 => """ G Beevers \n \t\t\t\t\t\t\t\t """ 5 => """ U de Faire \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(02)08089-3" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2002" "volumen" => "359" "paginaInicial" => "995" "paginaFinal" => "1003" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11937178" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => """ D Klaus \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Z Kardiol" "fecha" => "1985" "volumen" => "74" "paginaInicial" => "153" "paginaFinal" => "169" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2936016" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Patients with uncontrolled hypertension or concomitant hypertension and benign prostatic hyperplasia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => """ R Zusman \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/clc.4960270203" "Revista" => array:6 [ "tituloSerie" => "Clin Cardiol" "fecha" => "2004" "volumen" => "27" "paginaInicial" => "63" "paginaFinal" => "69" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14979621" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Left ventricular hypertrophy–its reversion speeded up by enalaprilat" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ R Póvoa \n \t\t\t\t\t\t\t\t """ 1 => """ B Luna Filho \n \t\t\t\t\t\t\t\t """ 2 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 3 => """ L Antonangelo \n \t\t\t\t\t\t\t\t """ 4 => """ V Capellozzi \n \t\t\t\t\t\t\t\t """ 5 => """ N Murad \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "1997" "volumen" => "16" "paginaInicial" => "57" "paginaFinal" => "60" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The expression of nucleolar organizer regions in left ventricular hypertrophy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 1 => """ B Luna Filho \n \t\t\t\t\t\t\t\t """ 2 => """ R Póvoa \n \t\t\t\t\t\t\t\t """ 3 => """ L Antonangelo \n \t\t\t\t\t\t\t\t """ 4 => """ V Capellozi \n \t\t\t\t\t\t\t\t """ 5 => """ N Murad \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "1997" "volumen" => "16" "paginaInicial" => "53" "paginaFinal" => "55" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Myocardial hypertrophy due to isoproterenol. The preventive action of verapamil" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ R Póvoa \n \t\t\t\t\t\t\t\t """ 1 => """ MT Manzoli \n \t\t\t\t\t\t\t\t """ 2 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 3 => """ N Murad \n \t\t\t\t\t\t\t\t """ 4 => """ M Simões \n \t\t\t\t\t\t\t\t """ 5 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "1995" "volumen" => "14" "paginaInicial" => "847" "paginaFinal" => "851" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8541062" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib31" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Left ventricular hypertrophy: its prevention with enalapril" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ R Póvoa \n \t\t\t\t\t\t\t\t """ 1 => """ E Costa \n \t\t\t\t\t\t\t\t """ 2 => """ B Luna Filho \n \t\t\t\t\t\t\t\t """ 3 => """ N Murad \n \t\t\t\t\t\t\t\t """ 4 => """ A Costa \n \t\t\t\t\t\t\t\t """ 5 => """ M Simões \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "1995" "volumen" => "14" "paginaInicial" => "779" "paginaFinal" => "781" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib32" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => """ WB Kannel \n \t\t\t\t\t\t\t\t """ 1 => """ T Gordon \n \t\t\t\t\t\t\t\t """ 2 => """ WP Castelli \n \t\t\t\t\t\t\t\t """ 3 => """ JR Margolis \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7326/0003-4819-72-6-813" "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1970" "volumen" => "72" "paginaInicial" => "813" "paginaFinal" => "822" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4247338" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib33" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ V Palmieri \n \t\t\t\t\t\t\t\t """ 1 => """ B Dahlöf \n \t\t\t\t\t\t\t\t """ 2 => """ V DeQuattro \n \t\t\t\t\t\t\t\t """ 3 => """ N Sharpe \n \t\t\t\t\t\t\t\t """ 4 => """ JN Bella \n \t\t\t\t\t\t\t\t """ 5 => """ G de Simone \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0735-1097(99)00396-4" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "1999" "volumen" => "34" "paginaInicial" => "1625" "paginaFinal" => "1632" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10551715" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib34" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Regression of left ventricular hypertrophy with echocardiography: some lessons from the LIVE study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => """ P Gosse \n \t\t\t\t\t\t\t\t """ 1 => """ O Dubourg \n \t\t\t\t\t\t\t\t """ 2 => """ P Gueret \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00004872-200301000-00032" "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "2003" "volumen" => "21" "paginaInicial" => "217" "paginaFinal" => "221" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12544454" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib35" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of baroreflex function in young spontaneously hypertensive rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 1 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 2 => """ A Meneghini \n \t\t\t\t\t\t\t\t """ 3 => """ M Ferreira \n \t\t\t\t\t\t\t\t """ 4 => """ N Murad \n \t\t\t\t\t\t\t\t """ 5 => """ C Ferreira Filho \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/s0066-782x2009000300009" "Revista" => array:6 [ "tituloSerie" => "Arq Bras Cardiol" "fecha" => "2009" "volumen" => "92" "paginaInicial" => "205" "paginaFinal" => "215" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19390709" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib36" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra-strain variations of baroreflex sensitivity in young Wistar-Kyoto rats" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 1 => """ C Imaizumi \n \t\t\t\t\t\t\t\t """ 2 => """ LC de Abreu \n \t\t\t\t\t\t\t\t """ 3 => """ E Colombari \n \t\t\t\t\t\t\t\t """ 4 => """ MA Sato \n \t\t\t\t\t\t\t\t """ 5 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Clin Invest Med" "fecha" => "2009" "volumen" => "32" "paginaInicial" => "e251" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib37" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiac baroreflex is already blunted in eight weeks old spontaneously hypertensive rats" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => """ JR Cisternas \n \t\t\t\t\t\t\t\t """ 1 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 2 => """ TB Alves \n \t\t\t\t\t\t\t\t """ 3 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ 4 => """ M Petenusso \n \t\t\t\t\t\t\t\t """ 5 => """ JR Breda \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1755-7682-3-2" "Revista" => array:5 [ "tituloSerie" => "Int Arch Med" "fecha" => "2010" "volumen" => "3" "paginaInicial" => "2" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20181028" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib38" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Baroreflex sensitivity variability in juvenile spontaneously hypertensive rats" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 1 => """ LC Abreu \n \t\t\t\t\t\t\t\t """ 2 => """ E Colombari \n \t\t\t\t\t\t\t\t """ 3 => """ MA Sato \n \t\t\t\t\t\t\t\t """ 4 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Cardiovasc J Afr" "fecha" => "2010" "volumen" => "21" "paginaInicial" => "132" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20532450" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib39" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Strain differences in baroceptor reflex in adult wistar kyoto rats" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ VE Valenti \n \t\t\t\t\t\t\t\t """ 1 => """ LC de Abreu \n \t\t\t\t\t\t\t\t """ 2 => """ C Imaizumi \n \t\t\t\t\t\t\t\t """ 3 => """ M Petenusso \n \t\t\t\t\t\t\t\t """ 4 => """ C Ferreira \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1590/S1807-59322010000200013" "Revista" => array:6 [ "tituloSerie" => "Clinics" "fecha" => "2010" "volumen" => "65" "paginaInicial" => "203" "paginaFinal" => "208" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20186305" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib40" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => """ BM Mayosi \n \t\t\t\t\t\t\t\t """ 1 => """ PJ Avery \n \t\t\t\t\t\t\t\t """ 2 => """ M Farrall \n \t\t\t\t\t\t\t\t """ 3 => """ B Keavney \n \t\t\t\t\t\t\t\t """ 4 => """ H Watkins \n \t\t\t\t\t\t\t\t """ ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eur Heart J" "fecha" => "2008" "volumen" => "29" "paginaInicial" => "525" "paginaFinal" => "530" ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack638809" "titulo" => "Acknowledgments" "texto" => "<p id="para260" class="elsevierStylePara elsevierViewall">Our studies received financial support from NEPAS (Núcleo de Estudos, Pesquisas e Assessoria à Saúde da Faculdade de Medicina do ABC), Capes (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), and FAPESP (Fundação de Amparo a Pesquisa do Estado de São Paulo).</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/18075932/0000006500000007/v1_202212010714/S1807593222023821/v1_202212010714/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/18075932/0000006500000007/v1_202212010714/S1807593222023821/v1_202212010714/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1807593222023821?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 0 | 5 |
2024 October | 57 | 24 | 81 |
2024 September | 78 | 15 | 93 |
2024 August | 64 | 15 | 79 |
2024 July | 52 | 14 | 66 |
2024 June | 38 | 15 | 53 |
2024 May | 49 | 10 | 59 |
2024 April | 67 | 14 | 81 |
2024 March | 41 | 9 | 50 |
2024 February | 42 | 13 | 55 |
2024 January | 46 | 11 | 57 |
2023 December | 48 | 27 | 75 |
2023 November | 43 | 20 | 63 |
2023 October | 51 | 24 | 75 |
2023 September | 36 | 29 | 65 |
2023 August | 20 | 11 | 31 |
2023 July | 13 | 14 | 27 |
2023 June | 25 | 8 | 33 |
2023 May | 24 | 2 | 26 |
2023 April | 42 | 1 | 43 |
2023 March | 19 | 1 | 20 |
2023 February | 7 | 1 | 8 |
2023 January | 23 | 11 | 34 |
2022 December | 41 | 1 | 42 |